115 related articles for article (PubMed ID: 9708519)
1. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells.
Sedelnikova OA; Panyutin IG; Thierry AR; Neumann RD
J Nucl Med; 1998 Aug; 39(8):1412-8. PubMed ID: 9708519
[TBL] [Abstract][Full Text] [Related]
2. Cell killing induced by decay of 125I during the cell cycle: comparison of 125I-antipyrine with 125I-bovine serum albumin.
Miyazaki N; Shinohara K
Radiat Res; 1993 Feb; 133(2):182-6. PubMed ID: 8438059
[TBL] [Abstract][Full Text] [Related]
3. Radiotoxicity of 125I in mammalian cells.
Kassis AI; Fayad F; Kinsey BM; Sastry KS; Taube RA; Adelstein SJ
Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
[TBL] [Abstract][Full Text] [Related]
4. Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.
Kassis AI; Fayad F; Kinsey BM; Sastry KS; Adelstein SJ
Radiat Res; 1989 May; 118(2):283-94. PubMed ID: 2727257
[TBL] [Abstract][Full Text] [Related]
5. Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.
Narra VR; Howell RW; Harapanhalli RS; Sastry KS; Rao DV
J Nucl Med; 1992 Dec; 33(12):2196-201. PubMed ID: 1460515
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes.
Kassis AI; Sastry KS; Adelstein SJ
Radiat Res; 1987 Jan; 109(1):78-89. PubMed ID: 3809393
[TBL] [Abstract][Full Text] [Related]
7. Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival.
Walicka MA; Adelstein SJ; Kassis AI
Radiat Res; 1998 Feb; 149(2):142-6. PubMed ID: 9457893
[TBL] [Abstract][Full Text] [Related]
8. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ
Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose.
DeSombre ER; Shafii B; Hanson RN; Kuivanen PC; Hughes A
Cancer Res; 1992 Oct; 52(20):5752-8. PubMed ID: 1394199
[TBL] [Abstract][Full Text] [Related]
10. Chemical modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian cells in vitro.
Walicka MA; Adelstein SJ; Kassis AI
Int J Radiat Biol; 2001 May; 77(5):625-30. PubMed ID: 11382341
[TBL] [Abstract][Full Text] [Related]
11. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
Schomäcker K; Fischer T; Böttcher B; Mraheel SA; Scharl A; Gabruk-Szostak B; Scheidhauer K; Göhring UJ; Meller-Rehbein B; Shukla SK; Schicha H
Nuklearmedizin; 1998 Jun; 37(4):134-40. PubMed ID: 9650213
[TBL] [Abstract][Full Text] [Related]
13. Radiotoxicity of intranuclear 125I atoms not bound to DNA.
Commerford SL; Bond VP; Cronkite EP; Reincke U
Int J Radiat Biol Relat Stud Phys Chem Med; 1980 May; 37(5):547-54. PubMed ID: 6967467
[TBL] [Abstract][Full Text] [Related]
14. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J
J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells.
Ruozi B; Montanari M; Vighi E; Tosi G; Tombesi A; Battini R; Restani C; Leo E; Forni F; Vandelli MA
J Liposome Res; 2009; 19(3):241-51. PubMed ID: 19694606
[TBL] [Abstract][Full Text] [Related]
17. Assessment of DNA damage produced by 125I-triplex-forming oligonucleotides in cells.
Sedelnikova OA; Panyutin IV; Neumann RD; Bonner WM; Panyutin IG
Int J Radiat Biol; 2004; 80(11-12):927-31. PubMed ID: 15764404
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers.
Feinendegen LE; Neumann RD
Int J Radiat Biol; 2004; 80(11-12):813-22. PubMed ID: 15764388
[TBL] [Abstract][Full Text] [Related]
19. Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridine.
Morgenroth A; Deisenhofer S; Glatting G; Kunkel FH; Dinger C; Zlatopolskiy B; Vogg AT; Kull T; Reske SN
Clin Cancer Res; 2008 Nov; 14(22):7311-9. PubMed ID: 19010846
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
Wilson KD; Raney SG; Sekirov L; Chikh G; deJong SD; Cullis PR; Tam YK
Int Immunopharmacol; 2007 Aug; 7(8):1064-75. PubMed ID: 17570323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
